Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.62 | N/A |
| PEG Ratio (TTM) | -3.15 | N/A |
| P/S Ratio (TTM) | 4.80 | N/A |
| P/B Ratio (TTM) | 1.38 | N/A |
| P/FCF Ratio (TTM) | 8.80 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.58 | N/A |
| Price to 5YR AVG FCF Ratio | 10.65 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.52% | N/A |
| ROE (TTM) | 8.22% | N/A |
| Net Profit Margin (TTM) | 28.89% | N/A |
| ROIC 5YR AVG | 4.58% | N/A |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.24% | -24.09% | 5.65% |
| Revenue | 0.83% | -5.05% | 3.17% |
| Net Income | -1.50% | -17.50% | 4.89% |
| Cash Flow | 6.32% | 91.94% | 64.19% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.75 | N/A |
| Quick Ratio (TTM) | 3.75 | N/A |
| D/E Ratio (TTM) | 1.19 | N/A |
| Interest Coverage (TTM) | 2.74 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 0.52 | N/A |
| LTL to 5YR AVG FCF | 15.16 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.27% | N/A |